Docoh
Loading...

30 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
, penalties and sanctions, and our brand and reputation could be harmed. The FDA and other regulatory agencies strictly regulate the marketing … . In addition, management’s attention could be diverted from our business operations, significant legal expenses could be incurred, and our brand and reputation
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
or marketing of our products, product liability claims and significant fines, penalties and sanctions, and our brand and reputation could be harmed … , significant legal expenses could be incurred, and our brand and reputation could be damaged. The FDA has also requested that companies enter
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
liability claims and significant fines, penalties and sanctions, and our brand and reputation could be harmed. The FDA and other regulatory agencies … be incurred, and our brand and reputation could be damaged. The FDA has also requested that companies enter into consent decrees or permanent
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
fines, penalties and sanctions, and our brand and reputation could be harmed. The FDA and other regulatory agencies strictly regulate the marketing … and reputation could be damaged. The FDA has also requested that companies enter into consent decrees or permanent injunctions under which specified
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
or marketing of our products, product liability claims and significant fines, penalties and sanctions, and our brand and reputation could be harmed … operations, significant legal expenses could be incurred, and our brand and reputation could be damaged. The FDA has also requested that companies enter
10-K
a3xahf t1lng
5 Mar 20
Annual report
7:00pm
S-1
jid 5nt4am8ekj9
13 Dec 19
IPO registration
5:32pm
10-K/A
kahx1h2o e0bqttai
5 Apr 19
Annual report (amended)
9:40pm
10-K
vdwce6i
28 Mar 19
Annual report
5:25pm
424B3
xge6qmj
9 Nov 18
Prospectus supplement
5:04pm
S-1/A
ggqv6h37m7twjwdko8
30 Oct 18
IPO registration (amended)
4:19pm
S-1/A
y3hduk6ksvq83yz1te3z
9 Oct 18
IPO registration (amended)
5:32pm
S-1/A
6lvy9rfqf 4f2jogk
13 Sep 18
IPO registration (amended)
8:00pm
S-1
2w52zf9m
29 Jul 18
IPO registration
8:00pm
10-K/A
axm9ete14zmno hu
16 Apr 18
Annual report (amended)
8:00pm
10-K
etl1 b8c5d8l04d
15 Apr 18
Annual report
8:00pm
8-K/A
6n1 115sp4t9cd2gn
16 Oct 17
Entry into a Material Definitive Agreement
8:00pm
8-K
bpdcskr
11 Oct 17
Entry into a Material Definitive Agreement
8:00pm
10-K
ar1p2etap4wfw7ge
13 Apr 15
Annual report
8:00pm
8-K
EX-99.1
a3jj3
28 Oct 14
Entry into a Material Definitive Agreement
8:00pm